CDK2 and neoplasm: It reduces the expression of cyclin D1, cyclin kinase-dependent kinase 2 (CDK2), cdc2/cyclin B complex, and other cell cycle-related proteins, and blocks tumor cells from G1 / S phase and G2 / M phase, thus exerting an antitumor effect [55-58].